Replies to post #5658 on GTC Biotherapeutics (fka GTCB)

[kris_kade]

We thought initially the ATRYN market in Europe is just 'proof of concept' but it obviously has balooned to a lucrative proposition especially on the pricing side.

So why GTCB & LEO have not issued any kind of PR yet ? And we have to find the info. thru some articles...

What are they waiting for ?